Flora Growth Corp. (FLGC)
USD 0.46
(0.65%)
USD 0.46
(0.65%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -45.87 Million USD | -206.52% |
| 2022 | -17.91 Million USD | 131.25% |
| 2021 | -20.61 Million USD | -55.04% |
| 2020 | -14.19 Million USD | -337.69% |
| 2019 | -2.79 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -2.6 Million USD | 9.46% |
| 2024 Q1 | -785 Thousand USD | 56.16% |
| 2023 Q1 | -2.1 Million USD | -109.44% |
| 2023 FY | - USD | -206.52% |
| 2023 Q4 | -2.39 Million USD | -867.34% |
| 2023 Q3 | -248 Thousand USD | 94.04% |
| 2023 Q2 | -4.15 Million USD | -97.44% |
| 2022 Q2 | -5.78 Million USD | 19.91% |
| 2022 FY | - USD | 131.25% |
| 2022 Q1 | -7.21 Million USD | 13.28% |
| 2022 Q4 | 22.31 Million USD | 757.75% |
| 2022 Q3 | -3.39 Million USD | 41.31% |
| 2021 FY | - USD | -55.04% |
| 2021 Q1 | -2.51 Million USD | 49.38% |
| 2021 Q4 | -8.32 Million USD | -134.75% |
| 2021 Q3 | -3.54 Million USD | -23.56% |
| 2021 Q2 | -2.86 Million USD | -14.01% |
| 2020 Q3 | -4.97 Million USD | -187.93% |
| 2020 Q2 | -1.72 Million USD | -185.79% |
| 2020 FY | - USD | -337.69% |
| 2020 Q1 | -604.11 Thousand USD | 0.0% |
| 2020 Q4 | -4.97 Million USD | 0.0% |
| 2019 Q2 | -1.89 Million USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 308.32 Million USD | 114.877% |
| Embecta Corp. | 245.4 Million USD | 118.692% |
| ANI Pharmaceuticals, Inc. | 109.32 Million USD | 141.959% |
| Dynavax Technologies Corporation | 9.66 Million USD | 574.55% |
| Esperion Therapeutics, Inc. | -150.1 Million USD | 69.442% |
| Pacira BioSciences, Inc. | 162.89 Million USD | 128.159% |
| PainReform Ltd. | -9.56 Million USD | -379.36% |
| Aquestive Therapeutics, Inc. | 1.18 Million USD | 3980.711% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -1099.398% |
| SCYNEXIS, Inc. | 73.47 Million USD | 162.426% |
| China SXT Pharmaceuticals, Inc. | -2.35 Million USD | -1851.076% |
| Cosmos Health Inc. | -17.06 Million USD | -168.846% |
| Journey Medical Corporation | 1.92 Million USD | 2487.819% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -1099.398% |
| Safety Shot Inc | -12.18 Million USD | -276.441% |
| Alpha Teknova, Inc. | -25.53 Million USD | -79.608% |
| Intra-Cellular Therapies, Inc. | -158.85 Million USD | 71.124% |
| Bright Green Corporation | - USD | Infinity% |
| Procaps Group, S.A. | 104.02 Million USD | 144.094% |
| Theratechnologies Inc. | -10.31 Million USD | -344.787% |
| Harrow Health, Inc. | 9.72 Million USD | 571.768% |
| Sonoma Pharmaceuticals, Inc. | -4.52 Million USD | -913.702% |
| Biofrontera Inc. | -18.45 Million USD | -148.577% |
| DURECT Corporation | -24.68 Million USD | -85.829% |
| Supernus Pharmaceuticals, Inc. | 98.26 Million USD | 146.681% |
| Cronos Group Inc. | -72.14 Million USD | 36.423% |
| OptiNose, Inc. | -15.55 Million USD | -194.927% |
| Ironwood Pharmaceuticals, Inc. | -924.86 Million USD | 95.04% |
| Kala Pharmaceuticals, Inc. | -36.08 Million USD | -27.127% |
| RedHill Biopharma Ltd. | 26.26 Million USD | 274.635% |
| Organogenesis Holdings Inc. | 36.03 Million USD | 227.307% |
| Guardion Health Sciences, Inc. | -3.92 Million USD | -1069.451% |
| Cumberland Pharmaceuticals Inc. | -710.85 Thousand USD | -6352.838% |
| Radius Health, Inc. | 38.31 Million USD | 219.734% |
| Universe Pharmaceuticals INC | -3.21 Million USD | -1326.719% |
| ProPhase Labs, Inc. | -14.82 Million USD | -209.368% |
| Phibro Animal Health Corporation | 84.6 Million USD | 154.215% |
| Procaps Group S.A. | 104.02 Million USD | 144.094% |
| Alvotech | -484.86 Million USD | 90.54% |
| TherapeuticsMD, Inc. | -8.4 Million USD | -446.006% |
| Viatris Inc. | 3.51 Billion USD | 101.304% |
| Rockwell Medical, Inc. | -4.69 Million USD | -877.205% |
| Aytu BioPharma, Inc. | -1.01 Million USD | -4432.609% |
| SIGA Technologies, Inc. | 84.15 Million USD | 154.504% |
| Tilray Brands, Inc. | -72.84 Million USD | 37.029% |
| Lifecore Biomedical, Inc. | 812 Thousand USD | 5749.015% |
| Shineco, Inc. | -26.55 Million USD | -72.743% |
| PetIQ, Inc. | 81.48 Million USD | 156.292% |
| Regencell Bioscience Holdings Limited | -3.61 Million USD | -1167.958% |
| Incannex Healthcare Limited | -18.5 Million USD | -147.892% |
| Neurocrine Biosciences, Inc. | 416.1 Million USD | 111.024% |
| Alimera Sciences, Inc. | 7.27 Million USD | 730.429% |
| Silver Spike Investment Corp. | 7.34 Million USD | 724.923% |
| Assertio Holdings, Inc. | -222.44 Million USD | 79.379% |
| Shuttle Pharmaceuticals Holdings, Inc. | -3.99 Million USD | -1049.437% |
| Petros Pharmaceuticals, Inc. | -4.21 Million USD | -989.065% |
| Clever Leaves Holdings Inc. | -16.8 Million USD | -172.971% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | -128.998% |
| Avadel Pharmaceuticals plc | -149.12 Million USD | 69.241% |
| Hempacco Co., Inc. | -12.77 Million USD | -259.109% |
| Talphera, Inc. | -9.84 Million USD | -366.064% |
| Alvotech | -484.86 Million USD | 90.54% |
| Eagle Pharmaceuticals, Inc. | 77.5 Million USD | 159.186% |
| Lantheus Holdings, Inc. | 491 Million USD | 109.342% |
| Currenc Group, Inc. | -1.9 Million USD | -2313.481% |
| Kamada Ltd. | 21.53 Million USD | 313.012% |
| Indivior PLC | 66 Million USD | 169.5% |
| Evoke Pharma, Inc. | -7.29 Million USD | -529.02% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | -128.998% |
| Evolus, Inc. | -41.81 Million USD | -9.711% |
| HUTCHMED (China) Limited | 25.52 Million USD | 279.685% |
| Amphastar Pharmaceuticals, Inc. | 241.46 Million USD | 118.997% |
| Akanda Corp. | -27.73 Million USD | -65.383% |